Cargando…
Cost and value in liver disease guidelines: 2011–2022
Chronic liver disease (CLD) is associated with rising health care utilization and cost. We aimed to describe the frequency of cost/value (C/V) statements in CLD-related clinical guidance documents (CGDs). METHODS: CGD with a focus on CLD published between January 2011 and February 2022 from 3 US soc...
Autores principales: | Aby, Elizabeth S., Kaplan, Alyson, Ufere, Nneka N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827964/ https://www.ncbi.nlm.nih.gov/pubmed/36633489 http://dx.doi.org/10.1097/HC9.0000000000000001 |
Ejemplares similares
-
The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis
por: Kochar, Bharati, et al.
Publicado: (2022) -
#LiverTwitter: An Emerging Tool for Liver Education and Research
por: Mikolajczyk, Adam E., et al.
Publicado: (2020) -
Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach
por: Patel, Arpan A., et al.
Publicado: (2021) -
Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: Haddadin, Yazan, et al.
Publicado: (2023) -
Review article: current and emerging therapies for the management of cirrhosis and its complications
por: Tapper, Elliot B., et al.
Publicado: (2022)